Heston MB, Teague JP, Cody KA, Deming Y, Ruiz de Chavez E, Morse J, Chin NA, Engelman CD, Chappell RJ, Langhough RE, Gleason CE, Clark LR, Zuelsdorff ML, Betthauser TJ; Alzheimer’s Disease Neuroimaging Initiative. Factors associated with age at tau pathology onset and time from tau onset to dementia. medRxiv [Preprint]. 2025 Mar 13:2025.03.11.25323773.
Panagiotopoulos N, Wolfson T, Harris DT, Batakis D, Agni R, Ceriani L, Covarrubias Y, Hamilton G, Middleton MS, Martins VF, Gamst AC, Oechtering TH, Sappenfield R, Horgan S, Grunvald E, Funk LM, Jacobsen GR, Lidor AO, Goodman JA, Khoury SB, Sirlin CB, Reeder SB. Proton density fat fraction for diagnosis of metabolic dysfunction associated steatotic liver disease. Hepatology. 2025 Mar 25.
Metzler LAP, Metzger JM, Gerred KJ, Emborg ME, Kapoor A. Expression patterns of blood-based biomarkers of neurodegeneration and inflammation across adulthood in rhesus macaques. Exp Gerontol. 2025 Mar 21;203:112736.
Cody KA, Du L, Studer RL, Jonaitis EM, Asthana S, Christian BT, Chin NA, Kirmess KM, Meyer MR, Yarasheski KE, West T, Verghese PB, Braunstein JB, Betthauser TJ, Langhough RE, Johnson SC. Accuracy of plasma biomarkers to detect Alzheimer’s disease proteinopathy prior to dementia. Alzheimers Dement. 2025 Mar;21(3):e14570.
Marlin A, Tran PN, Dierolf M, DeLuca M, Joaqui Joaqui MA, Glaser OM, Koller AJ, Alucio-Sarduy E, Gork M, Śmiłowicz D, Pierre V, Engle JW, Boros E. Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV). Bioconjug Chem. 2025 Mar 18.
Blum EG, Edmunds KJ, Breidenbach B, Cook N, Driscoll I, Lose SR, Bendlin BB, Ma Y, Christian B, Betthauser TJ, Sager M, Asthana S, Johnson SC, Cook DB, Okonkwo OC. Physical activity and APOE neuropathology score modify the association of age and [11C]-PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer’s disease.
medRxiv [Preprint]. 2025 Mar 5:2025.03.01.25323157.
Paulsen AJ, Driscoll I, Breidenbach BM, Glittenberg MP, Lose SR, Ma Y, Sager MA, Carlsson CM, Gallagher CL, Hermann BP, Blennow K, Zetterberg H, Asthana S, Johnson SC, Betthauser TJ, Christian BT, Cook DB, Okonkwo OC. The impact of cardiorespiratory fitness on Alzheimer’s disease biomarkers and their relationships with cognitive decline. medRxiv [Preprint]. 2025 Mar 6:2025.03.03.25323245.
Parks AE, Hansen AK, Pogue BW. Hybrid Monte Carlo model for efficient tissue Cherenkov emission estimation to assess changes from beam size, energy and incidence. Phys Med. 2025 Apr;132:104956. Epub 2025 Mar 14.
Emborg ME, Metzger JM, D’Amour K, Colwell JC, Neumann LC, Zhang A, Federoff HJ. Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies. Brain Res Bull. 2025 Mar 12;224:111297.
Prieto C, Mossa-Basha M, Christodoulou A, Sheagren CD, Guo Y, Radjenovic A, Zhao X, Collins JD, Botnar RM, Wieben O. Highlights of the Society for Magnetic Resonance Angiography 2024 Conference. J Cardiovasc Magn Reson. 2025 Mar 12:101878.
Huang W, Wang T, Chao F, Yang Q, Mixdorf JC, Li L, Engle JW, Fan Y, Kang L, Cai W. ImmunoPET Imaging of Trop2 Expression in Bladder Cancer Using [64Cu]Cu-NOTA-Trodelvy. Mol Pharm. 2025 Mar 9.
Fowler AM. 18F-Fluoroestradiol PET/CT for Staging Low-Grade Estrogen Receptor-Positive Breast Cancer. Radiology. 2025 Mar;314(3):e250135.